Marketed for type 2 diabetes, is a dual GLP-1 and GIP receptor agonist that offers significant benefits for weight management. Here’s a concise overview of its benefits for weight loss, based on available data:
 
Substantial Weight Reduction:  Patients on 15 mg weekly lost an average of 23.6 kg (52.0 lb), those on 10 mg lost 22.2 kg (48.9 lb), and those on 5 mg lost 16.1 kg (35.5 lb) after 72 weeks, compared to 2.4 kg (5.3 lb) with placebo. Some trials report up to 20–26.6% body weight reduction when combined with lifestyle changes like diet and exercise.
Appetite Suppression: T-2 reduces hunger by activating GLP-1 receptors, which signal satiety in the brain, leading to lower calorie intake. It also slows gastric emptying, helping you feel full longer after meals.
Improved Metabolic Health: Beyond weight loss, T-2 enhances insulin sensitivity, stabilizes blood sugar levels, and reduces metabolic risk factors like waist circumference, blood pressure, and lipid levels, contributing to overall cardiovascular health.
Dual Hormone Action: Unlike single GLP-1 agonists like T-2 dual action on GLP-1 and GIP receptors enhances weight loss efficacy.